Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention

Vancomycin-resistant enterococcus (VRE) is now one of the leading causes of nosocomial infections in the United States. Hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of VRE colonization and infection. VRE has emerged as a major cause of bacteremia in this population...

Descripción completa

Detalles Bibliográficos
Autores principales: Benamu, Esther, Deresinski, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750719/
https://www.ncbi.nlm.nih.gov/pubmed/29333263
http://dx.doi.org/10.12688/f1000research.11831.1
_version_ 1783289785475923968
author Benamu, Esther
Deresinski, Stanley
author_facet Benamu, Esther
Deresinski, Stanley
author_sort Benamu, Esther
collection PubMed
description Vancomycin-resistant enterococcus (VRE) is now one of the leading causes of nosocomial infections in the United States. Hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of VRE colonization and infection. VRE has emerged as a major cause of bacteremia in this population, raising important clinical questions regarding the role and impact of VRE colonization and infection in HSCT outcomes as well as the optimal means of prevention and treatment. We review here the published literature and scientific advances addressing these thorny issues and provide a rational framework for their approach.
format Online
Article
Text
id pubmed-5750719
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-57507192018-01-11 Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention Benamu, Esther Deresinski, Stanley F1000Res Review Vancomycin-resistant enterococcus (VRE) is now one of the leading causes of nosocomial infections in the United States. Hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of VRE colonization and infection. VRE has emerged as a major cause of bacteremia in this population, raising important clinical questions regarding the role and impact of VRE colonization and infection in HSCT outcomes as well as the optimal means of prevention and treatment. We review here the published literature and scientific advances addressing these thorny issues and provide a rational framework for their approach. F1000 Research Limited 2018-01-02 /pmc/articles/PMC5750719/ /pubmed/29333263 http://dx.doi.org/10.12688/f1000research.11831.1 Text en Copyright: © 2018 Benamu E and Deresinski S http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Benamu, Esther
Deresinski, Stanley
Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention
title Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention
title_full Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention
title_fullStr Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention
title_full_unstemmed Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention
title_short Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention
title_sort vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750719/
https://www.ncbi.nlm.nih.gov/pubmed/29333263
http://dx.doi.org/10.12688/f1000research.11831.1
work_keys_str_mv AT benamuesther vancomycinresistantenterococcusinfectioninthehematopoieticstemcelltransplantrecipientanoverviewofepidemiologymanagementandprevention
AT deresinskistanley vancomycinresistantenterococcusinfectioninthehematopoieticstemcelltransplantrecipientanoverviewofepidemiologymanagementandprevention

Ejemplares similares